The Valley Desk

NCT04561362 · Interventional trial

Study BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions Advanced Solid Tumor, Breast Neoplasms, Hormone Receptor Positive, HER2-low Neoplasms, Hormone Receptor Positive, HER2-negative Neoplasms, Non-Small-Cell Lung Neoplasms, Ovarian Neoplasm, Triple Negative Breast Neoplasms, Urinary Bladder Neoplasm

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov